Marta Velázquez Gil

Marta Velázquez Gil

Auto-generated profile, based on publicly available information

Marta Velázquez Gil

Universidad Francisco de Vitoria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2025 in Cogent Social Sciences
Verified
Journal Article
Open access
VFVerónica Fernández
Verónica Fernández
PRPaloma Redondo-Corcobado
Paloma Redondo-Corcobado
MGMarta Velázquez Gil
Marta Velázquez Gil

8 January 2026 in British Journal of Educational Studies
Verified
Journal Article
Open access
VFVerónica Fernández
Verónica Fernández
PRPaloma Redondo-Corcobado
Paloma Redondo-Corcobado
MGMarta Velázquez Gil
Marta Velázquez Gil

7 October 2026 in BMC Nutrition
Verified
Journal Article
Open access
PDF file
EREsther Nova Rebato
Esther Nova Rebato
MFMar Faya
Mar Faya
AMAndrea Muñoz-Domenjó
Andrea Muñoz-Domenjó
LPLigia Esperanza Díaz Prieto
Ligia Esperanza Díaz Prieto
SCSusana del Pozo de La Calle
Susana del Pozo de La Calle
AMAscensión Marcos
Ascensión Marcos
Background: Eating disorders (ED) are severe and complex psychiatric conditions characterized by the presence of abnormal eating patterns. An integrative biopsychosocial model has been developed to describe vulnerability to developing an ED, as well as its maintenance and treatment resistance. Potential predisposing factors for anorexia nervosa (AN) include neurobiological and genetic factors, psychological traits and early life experiences. More specifically, dysregulation of brain neurotransmitters and the reward systems, appetite-regulating neuropeptides, the hypothalamic–pituitary–adrenal (HPA) axis and the bidirectional communication between the gut microbiome and the brain have all been pointed out . However, studies relevant to characterizing the gut microbiota features in AN patients are still scarce and more research is needed to discern the mechanisms operating in specific stages of the disease and in specific diagnostic subtypes. Thus, the objective of this project is to investigate differences in gut microbiota composition and microbial-related metabolite levels between children and adolescents experiencing their first episode of ED and matched healthy controls. Additionally, we will study the associations between psychological variables, dietary patterns, microbiota composition, and neuroendocrine and inflammatory variables to generate hypotheses about the most important factors in the pathophysiology of ED. Methods: A cross-sectional, controlled study will be conducted with children and adolescents who have been newly diagnosed with an ED and have had symptoms for less than one year. Healthy preadolescents and adolescents will serve as the control group. The study will include an assessment of clinical status, medical history, early life experiences, psychometric tests, dietary patterns, and gut microbiota composition and function (shotgun metagenomics). Additionally, appetite-regulating peptides, neurotransmitters, inflammatory cytokines, and SCFAs will be analyzed. For patients willing to undergo a second assessment, clinical variables, microbiota, and blood biomarkers will be analyzed after one year of treatment. Discussion: Understanding the regulatory mechanisms of physiological functions affected by ED, such as appetite control, reward systems, and energy homeostasis, as well as the role of gut microbiota in these systems, could help advance the design of personalized treatments. Trial registration: ClinicalTrials.gov ID: NCT07066033. Released on July 3, 2025.